Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,224,800 | 2,384,900 | 2,591,300 | 2,913,700 | 2,343,900 |
| Marketable Securities | 1,355,000 | 1,942,700 | 1,269,100 | 1,562,200 | 2,093,500 |
| Receivables | 2,024,900 | 2,133,600 | 2,092,600 | 1,880,500 | 1,933,500 |
| Inventories | 1,027,700 | 952,700 | 858,800 | 804,200 | 751,800 |
| Other current assets | 1,210,700 | 1,079,900 | 1,195,400 | 1,221,200 | 1,325,500 |
| TOTAL | $7,843,100 | $8,493,800 | $8,007,200 | $8,381,800 | $8,448,200 |
| Non-Current Assets | |||||
| PPE Net | 3,359,900 | 3,330,700 | 3,281,600 | 3,247,300 | 3,138,100 |
| Investments And Advances | 2,844,700 | 2,406,100 | 2,100,100 | 2,660,900 | 3,052,700 |
| Intangibles | 9,079,300 | 9,134,800 | 9,198,900 | 9,285,200 | 9,138,500 |
| Other Non-Current Assets | 1,807,100 | 2,146,400 | 3,531,400 | 3,659,100 | 3,706,500 |
| TOTAL | $17,091,000 | $17,018,000 | $18,112,000 | $18,852,500 | $19,035,800 |
| Total Assets | $24,934,100 | $25,511,800 | $26,119,200 | $27,234,300 | $27,484,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 398,400 | 383,900 | 389,000 | 530,800 | 382,200 |
| Accrued Expenses | 3,286,200 | 2,486,500 | 2,437,800 | 2,765,800 | 2,429,100 |
| TOTAL | $3,804,000 | $3,447,100 | $4,638,600 | $4,863,800 | $4,432,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,425,000 | 7,423,800 | 4,459,900 | 4,459,000 | 4,458,200 |
| Other Non-Current Liabilities | 1,834,800 | 1,825,800 | 1,767,500 | 1,761,600 | 1,781,400 |
| TOTAL | $10,385,600 | $10,775,500 | $8,943,700 | $9,031,400 | $9,060,000 |
| Total Liabilities | $14,189,600 | $14,222,600 | $13,582,300 | $13,895,200 | $13,492,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 153,882 | 158,314 | 163,188 | 174,064 | 180,442 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 13,961,000 | 14,466,700 | 15,673,100 | 16,455,400 | 17,065,200 |
| Other shareholders' equity | -239,600 | -200,600 | -159,400 | -139,400 | -96,500 |
| TOTAL | $10,744,500 | $11,289,200 | $12,536,900 | $13,339,100 | $13,991,800 |
| Total Liabilities And Equity | $24,934,100 | $25,511,800 | $26,119,200 | $27,234,300 | $27,484,000 |